v        GLEN.jpg1                800px-Merck_Logo.svg

Indian pharma giant Glenmark pharamceuticals restrained by the Delhi High Court from making, marketing or selling its anti-diabetes medicines Zeta and Zeta on the ground that it had “prima facie” infringed the patent of US drug major Merck Sharp and Dohme (MSD).

A bench of justices S Ravindra Bhat and Najmi Waziri, while granting an interim injunction in favour of MSD, also said the price difference between the drugs of the two companies “is not so startling as to compel the court to infer that allowing Glenmark to sell the drug at depressed prices would result in increased access.”

>>Read more http://epaperbeta.timesofindia.com/Article.aspx?eid=31805&articlexml=PATENT-VIOLATION-HC-restrains-Glenmark-from-making-selling-08102015013037

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>